QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery
Clinical trial NCT03510897 · TERMINATED
Trial details
- NCT number
- NCT03510897
- Sponsor
- Quark Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-29
- Primary completion
- 2020-10-14
- Enrollment
- 1043
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.